Keep pulling the thread on Bristol Myers Squibb.
The radiotherapy sector has seen $15 billion in M&A and deal-making in the last few years, with major pharmaceutical companies like Bristol, Novartis, Bayer, and Lilly actively seeking assets.
EcoR1 Capital estimates Actis Oncology could be worth $10 billion, or $200 per share, if even one of its programs successfully makes it to market.
GeoNet operates the world's largest RTK network with 22,000 base stations, roughly twice the combined size of competitors Trimble, Hexagon, and Topcon.
GeoNet has achieved an annualized revenue run rate of $11 million and is growing more than 3x year-over-year.
GeoNet uses 80% of its revenue, currently $8.8 million per year, to buy back its GEOD tokens on the open market via the Solana blockchain.
Barry Diller has acquired 26% of MGM and recently made a bid to acquire the entire company for $48 per share.
MGM has bought back half of its stock float over the past six years.
MGM holds a license to open a casino in Osaka, Japan, which is scheduled to open in 2030.
Soreta Capital estimates MGM's Osaka casino will generate approximately $2 billion of EBITDA annually.
Soreta Capital predicts that MGM's stock could triple in value, potentially reaching over $100 or even $150 per share.
Talon Energy is currently valued at a $25 billion enterprise value, which is significantly below its estimated replacement cost of $45 billion.
The PJM grid operator forecasts a need for 106 gigawatts of new power generation in its region over the next 10 years.